In light of following high quality findings, we see that the problems discovered with covid’s experimental development and history and the implications for all vaccine rationale, have now been found to apply to the launch of all drugs. Lesson: Injury and death for profit protected from prosecution by billions of dollars efficiently sp…
In light of following high quality findings, we see that the problems discovered with covid’s experimental development and history and the implications for all vaccine rationale, have now been found to apply to the launch of all drugs. Lesson: Injury and death for profit protected from prosecution by billions of dollars efficiently spread around in the right places.
Summary: “Of 1567 eligible interventions [all medical drugs approved since 2008] , 87 (5.6%) had high quality evidence [ “clinical data that met the “high-quality” standard”] on first-listed primary outcomes, positive, statistically significant results and were rated by review authors as beneficial.” “94% of recently approved [since 2008] medications are not supported by high-quality evidence that demonstrates their benefits. “... over 1/3 being linked to adverse reactions that are being underreported. ... Nearly 10% of the approved medications were found to have “significant evidence of harm.”
In light of following high quality findings, we see that the problems discovered with covid’s experimental development and history and the implications for all vaccine rationale, have now been found to apply to the launch of all drugs. Lesson: Injury and death for profit protected from prosecution by billions of dollars efficiently spread around in the right places.
Summary: “Of 1567 eligible interventions [all medical drugs approved since 2008] , 87 (5.6%) had high quality evidence [ “clinical data that met the “high-quality” standard”] on first-listed primary outcomes, positive, statistically significant results and were rated by review authors as beneficial.” “94% of recently approved [since 2008] medications are not supported by high-quality evidence that demonstrates their benefits. “... over 1/3 being linked to adverse reactions that are being underreported. ... Nearly 10% of the approved medications were found to have “significant evidence of harm.”